Global Cardiology Surgery, Devices and Drugs Market 2022-2028

Global Cardiology Surgery, Devices, and Drugs Market Size, Share & Trends Analysis Report by Devices Types (Angioplasty, Cardiovascular Stents, Cardiovascular Catheters, Cardiac Rhythm Management, Cardiovascular Assistive Devices), by Drugs Types (Antithrombotic Drugs, Antidyslipidemic Drugs, Antihypertensive Drugs, Anti Stroke Drugs), By Surgery Types(Coronary Artery Bypass Grafting, Transmyocardial Laser Revascularization, Heart Valve Repair, Arrhythmia Treatment, Aneurysm Repair, and Heart Transplant) Forecast 2022-2028

The global cardiology surgery, devices, and drug market is anticipated to grow at a substantial CAGR of 7.4% during the forecast period. The report covers three major segments of the interventional cardiology market which include surgeries, devices, and drugs. Some of the major CVDs include coronary heart diseases, stroke, hypertensive heart diseases, inflammatory heart diseases, rheumatoid heart diseases, and others. Coronary heart diseases are the leading cause of death followed by strokes. The prevalence and incidence rate of heart diseases are on a rise; especially in major emerging countries such as India, China, and Japan. As per WHO, an estimated 17.9 million people died from cardiovascular in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. The Cardiology surgery devices, devices, and drugs market is anticipated to rise in the coming year. Another major factor driving the market includes medical tourism. Especially in emerging markets such as India, ASEAN countries, and China, the cost of surgery and treatment for cardiovascular diseases is low. In India, heart surgery costs around $1,500 whereas in the United States it costs 5 to 10 times more than India. Hence, many Americans prefer to travel to India for their treatment.

The global cardiology surgery, devices, and drug market is segmented based on devices types, drug types, and surgeries types. Based on devices types the market is segmented into angioplasty, cardiovascular stents, cardiovascular catheters, cardiac rhythm management, and cardiovascular assistive devices. Based on drugs types the market is sub-divided into antithrombotic drugs, antidyslipidemic drugs, antihypertensive drugs, and anti-stroke drugs. Based on by surgeries types the market is bifurcated into coronary artery bypass grafting, transmyocardial laser revascularization, heart valve repair, arrhythmia treatment, aneurysm repair, and heart transplant. Based on drug type, the antithrombotic drugs segment holds a major market share in the global cardiology surgery, devices, and drug market, owing to its wider application in reducing acute coronary syndromes and minimizing the risk of death, and Q waves myocardial infarction dramatically in recent years. Moreover, advancements in the treatment therapies such as catheter-directed thrombolysis and others in the usage of antithrombotic drugs for better clinical outcomes are projected to boost the growth of the antithrombotic drugs segment.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Asia-Pacific region is anticipated to grow at the fastest rate, due to the large number of patients pool suffering from cardiac diseases and the availability of a strong generic drug market in the emerging countries. In addition, manufacturers' interest in expanding to these Asian countries, will further fuel the growth in the near future.

The major companies serving the global cardiology surgery, devices, and drug market are Pfizer, Sanofi, AstraZeneca, Novartis, Bristol-Myers Squibb, Merck, Boston Scientific Corp., Medtronic, Sun Pharma, Roche Bayer, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2022, GE Healthcare entered into a collaboration with Boston Scientific to offer its heart-focused medical devices. Together, these offerings provide access to more advanced tools to improve every step of cardiac care, from diagnosis to interventional treatments. Additionally, these solution assists in unlocking the potential of interventional cardiology and delivered precision health to the region. Briding the industry gas, this partnership provides integration of cardiac care solutions, from cath labs to intravascular ultrasound, serving as a comprehensive portfolio for heart surgeons.

Research Methodology

The market study of the global cardiology surgery, devices, and drug market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Cardiology Surgery, Devices, and Drug Market Research and Analysis by Drug Types.
2. Global Cardiology Surgery, Devices, and Drug Market Research and Analysis by Device Types.
3. Global Cardiology Surgery, Devices, and Drug Market Research and Analysis by Surgery Types.

The Report Covers

• Comprehensive research methodology of the global cardiology surgery, devices, and drug market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global cardiology surgery, devices, and drug market.
• Insights about market determinants that are stimulating the global cardiology surgery, devices, and drug market.
• Detailed and extensive market segments with the regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.